• ATP, TCAIM, and Mitochondrial Metabolism

  2026-10-11

  A source-grounded overview of how the 2025 TCAIM study links mitochondrial proteostasis to OGDH regulation, with ATP discussed as metabolic context rather than as a demonstrated intervention.

• Neurotensin: Mechanism, Evidence, and Readout Limits

  2026-10-09

  Neurotensin is a Neurotensin receptor 1 activator with relevance to GPCR trafficking and miRNA regulation in gastrointestinal cells. This evidence-led analysis also explains why spectral-classification findings should inform assay interpretation without being mistaken for direct neurotensin evidence.

• HBPL Lipopolyplexes for Stable mRNA Delivery

  2026-10-09

  Meng and colleagues report a ternary lipid/hyperbranched polylysine/mRNA lipopolyplex designed to balance storage stability with intracellular mRNA release. The study links HBPL architecture to membrane-fusion-associated uptake, efficient protein expression, immune-cell activity, and sustained performance after storage, while also identifying important limits for translation beyond the reported models.

• NHE1, Olfr2, and Macrophage Atherosclerosis

  2026-10-08

  A 2025 Scientific Reports study identifies macrophage NHE1 as a downstream effector of octanal/Olfr2 signaling in atherosclerosis, linking calcium-dependent oxidative stress with inflammatory plaque biology. Using mouse and macrophage models, the authors show that NHE1 deficiency or inhibition attenuates octanal-associated foam-cell formation and inflammation, while the findings remain preclinical and mechanistic rather than clinical.

• Hyperbranched Lipopolyplexes for Stable mRNA Delivery

  2026-10-08

  Meng and colleagues describe a ternary lipid/hyperbranched poly-L-lysine/mRNA lipopolyplex designed to reconcile storage stability with intracellular mRNA release. The reported results link the HBPL core to efficient delivery in several experimental settings, while also indicating that the platform’s durability, mechanism, and translational relevance require further validation.

• How HBsAg Reprograms TBK1, Interferon, and Autophagy

  2026-10-07

  A 2025 Cell Death and Disease study identifies a mechanism by which hepatitis B surface antigen redirects TBK1 activity away from IRF3-dependent interferon signaling and toward autophagy-related responses. The findings connect HBsAg–TBK1 binding, incomplete autophagy, and HBV persistence while highlighting important limits in translating cell, mouse, and patient-tissue observations into therapeutic conclusions.

• Sumatriptan and Inflammation: Evidence Beyond Migraine

  2026-10-07

  Ala et al. synthesized evidence that sumatriptan, a 5-HT1 receptor agonist, may influence inflammatory signaling beyond its established role in migraine. Their review connects cytokine regulation, nitric oxide and CGRP pathways, and tissue-protection findings while emphasizing that most evidence remains preclinical and heterogeneous.

• Idoxuridine: From DNA Mechanism to Translation

  2026-10-06

  A translational perspective on Idoxuridine as a nucleoside analog and viral DNA synthesis inhibitor, with strategic guidance for mechanism-first antiviral research and a cautious comparison to human neuropharmacology evidence.

• Rgs16::GFP Screening for PDA Drug Combinations

  2026-10-06

  Layeghi-Ghalehsoukhteh and colleagues developed a connected cell-culture and mouse screening framework using Rgs16::GFP to prioritize treatments for pancreatic ductal adenocarcinoma. The study identified enhanced activity from combining gemcitabine, the HDAC inhibitor TSA, and JQ1, while also showing why biomarker-guided validation remains necessary before extrapolating results to human therapy.

• Idoxuridine: An Evidence-Led Research Framework

  2026-10-05

  Idoxuridine, also known as 5-iodo-2'-deoxyuridine, is examined here as a research tool for studying viral DNA synthesis inhibition. Rather than presenting a protocol, this article connects molecular mechanism, assay interpretation, product provenance, and lessons from human-neuron pharmacology.

• Ceramides Promote RGNNV Replication via Autophagy

  2026-10-05

  A 2026 Journal of Virology study used lipidomics and complementary perturbation evidence to identify ceramide accumulation as a pro-viral feature of red-spotted grouper nervous necrosis virus infection. The findings connect viral capsid protein activity, sphingolipid metabolism, and autophagy, while supporting ceramide flux as a potential host-directed research focus in aquaculture virology.

• TMB Substrate Solution for ELISA: Reading ISR Biology

  2026-10-04

  Learn how a TMB substrate solution for ELISA can support protein-level investigation of the integrated stress response without being mistaken for a direct measure of translation or ribosome biology. This evidence-focused guide connects assay interpretation with findings from a recent XPG-related Cockayne syndrome study.

• ICG001 and Wnt Signaling in Bone Research

  2026-10-03

  ICG001 is a research tool for examining CBP-dependent β-catenin transcription, while recent work links lithium-treated BMSC exosomes and Wnt10a signaling to enhanced osteogenesis. The evidence supports a plausible mechanistic research question, but does not establish ICG001 as a bone-regeneration treatment or validate its effects in the lithium–exosome model.

• Thermoresponsive PEG Shedding Improves mRNA Delivery

  2026-10-02

  The reference study introduces oxanorbornadiene-linked PEG–lipids that shed from lipid nanoparticles at programmable rates, addressing the trade-off between extracellular stability and cellular uptake. Its route-specific experiments show that rapid or intermediate PEG removal can improve pulmonary or systemic mRNA delivery while preserving the transport advantages of PEGylation.

• Affinity-Purified Goat Anti-Mouse IgG (H+L) Workflow

  2026-10-01

  Build sensitive, reproducible Western blot, ELISA, IHC, and ICC workflows with a broad-reactivity HRP secondary antibody. This guide translates mitochondrial calcium research into practical detection strategies, with starting conditions, controls, storage guidance, and troubleshooting for mouse primary antibodies.

8153 records 1/544 page Next 12345 下5页 Last page